Skip to content

A Comparison of Seroquel vs. Risperidone in Schizophrenia

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00034905
Enrollment
Unknown
Registered
2002-05-03
Start date
2001-07-31
Completion date
2002-09-30
Last updated
2013-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Brief summary

The purpose of this study is to show equal efficacy of both quetiapine and risperidone in subjects treated with study medication for up to 8 weeks.

Interventions

DRUGquetiapine fumarate vs risperidone

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Male / Female, 18-65 years old * Schizophrenia (as per DSM IV)

Exclusion criteria

* Concurrent use of psychotropic medication * Does not fulfill moderately ill on CGI

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026